Literature DB >> 2473109

Fine specificity of T cell recognition of the same peptide in association with different I-A molecules.

S J Brett1, K B Cease, C S Ouyang, J A Berzofsky.   

Abstract

The fine specificity of the response of T cell clones derived from B10.BR and B10.S congenic mouse strains restricted by I-Ak and I-As molecules, respectively, and which recognize the same 17 amino acid sequence (102-118) of myoglobin, has been investigated and compared with that of T cell clones specific for the same peptide with I-A.d The critical amino acid residues within the 102-118 region of myoglobin required for stimulation of I-Ak-and I-As-restricted T cell clones specific for this determinant were compared using a panel of synthetic peptide analogs. Residues 109, 113, and 116 were critical for stimulation of clones from both haplotypes, although the precise fine specificity varied, even among clones using the same restriction molecule. Residues 109 and 116 are also critical for stimulation of myoglobin-specific I-Ad-restricted clones (Berkower, I., L. A. Matis, G.K. Buckenmeyer, F.R. N. Gurd, D. L. Longo, and J. A. Berzofsky. J. Immunol. 132:1370, 1984). There was also considerable overlap in the size of the minimal determinant necessary for full activity: 106-118 for B10.BR and B10.D2 (Cease, K. B., I. Berkower, J. York-Jolley, and J. A. Berzofsky. J. Exp. Med. 164:1779, 1986) clones and 102-117 for B10.S clones. Despite this similarity in fine specificity, T cell clones were genetically restricted and could not be stimulated with the 102-118 peptide presented by Ia molecules of other haplotypes that could also present this epitope to syngeneic clones. These results suggest that binding of an immunogenic peptide to class II molecules is not sufficient to ensure recognition by a given T cell antigen receptor specific for the peptide, but do not indicate whether the major histocompatibility complex molecules interact directly with the T cell antigen receptor or induce a different recognizable conformation of the peptide.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473109

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Induction of a pharmacologically active clonotypic B cell response directed to an immunogenic region of the human beta 2-adrenergic receptor.

Authors:  J G Guillet; R Lengagne; Y Magnusson; K Tate; A D Strosberg; J Hoebeke
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.

Authors:  J A Berzofsky; C D Pendleton; M Clerici; J Ahlers; D R Lucey; S D Putney; G M Shearer
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus.

Authors:  A M Boots; J G Kusters; J M van Noort; K A Zwaagstra; E Rijke; B A van der Zeijst; E J Hensen
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

4.  Immunodominant regions for T helper-cell sensitization on the human nicotinic receptor alpha subunit in myasthenia gravis.

Authors:  M P Protti; A A Manfredi; C Straub; J F Howard; B M Conti-Tronconi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits.

Authors:  A A Manfredi; M P Protti; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

6.  Myasthenia gravis. CD4+ T epitopes on the embryonic gamma subunit of human muscle acetylcholine receptor.

Authors:  M P Protti; A A Manfredi; X D Wu; L Moiola; M W Dalton; J F Howard; B M Conti-Tronconi
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

7.  Ro/SSA inhibits the autologous mixed lymphocyte reaction.

Authors:  J Karsh; J B Harley; R Goldstein; A I Lazarovits
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

8.  Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity.

Authors:  Jens Hennecke; Don C Wiley
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.